Avantor announces J.T. Baker Cell Lysis Solution and J.T. Baker Endonuclease (NYSE:AVTR)

  • Avantor (NYSE:AVTR) on Monday announced the launch of two products that optimize the gene therapy harvest process – J.T. Baker Cell Lysis Solution and J.T. Baker Endonuclease.
  • The company said that pairing J.T. Baker Cell Lysis Solution with J.T. Baker Endonuclease can further reduce the number of steps at harvest.
  • Press release.